CaMK4 knockdown in ADPKD cells using CaMK4 shRNA (#2) decreased mTOR abundance by 65%, P-S6K by 50%, and total S6K by 25% compared to the cells treated with control shRNA (Figure 2A and C–E). Here, CAMK4 is linked to autosomal dominant polycystic kidney disease.